New coating technology being developed by Glasgow University could have implications both for implant wearers and for drug development pipelines, researchers are hoping.
The primary aim of the technology is to improve implant biocompatibility rates, by recreating the surrounding cells’ natural environment. However, it is also believed to have a use in drug development, as the coating can be used to recreate conditions such as a clotted vein, allowing researchers to more accurately predict how the drug will behave in real time use.
The technology can also be used to boost the manufacture of living cells, which are used to test drug toxicity.
